×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

cureTV – Empowering Patients Through Video

Katie Couric
The legendary broadcast journalist Katie Couric sat down with CURE® to discuss the setbacks she and her husband faced when pursuing new treatment and clinical trials.
Lowell Hart
With new ways to treat chemotherapy-induced side effects, it seems that chemotherapy, combined with checkpoint inhibitors, is here to stay for the foreseeable future, according to one expert.
R. Donald Harvey
One expert weighs the benefits and drawbacks of expanding clinical trials to be more inclusive and reflective of the general patient population with cancer.
Rolf Benirschke
Former NFL player Rolf Benirschke spoke to CURE® about his life-changing diagnosis and offers advice and encouragement to patients coping with a diagnosis of any kind.
Katie Couric
Katie Couric discussed the many challenges she faced while being a caregiver to her husband during his nine-month battle with colorectal cancer and shared how her career helped her to cope with the loss and turmoil in her life.
Jennifer King
Studies show that the social stigma can actually affect a patient’s level of care and lead to worse health outcomes.
Dr. Daniel McFarland
Tumor mutation burden may be an independent predictor of developing depression in patients with lung cancer, according to Dr. Daniel McFarland.
Katie Couric
Katie Couric spoke about the challenges she faced while caring for her late husband while maintaining a career and taking care of her daughters’ needs during their family’s unfortunate circumstances.
Dr. Michael Wang
Breakthroughs such as CAR-T cell therapy in the treatment of mantle cell lymphoma could help patients overcome drug resistance and ultimately live longer, according to Dr. Michael Wang.
Dr. Lowell Hart
Trilaciclib, an intravenous CDK 4/6 inhibitor, in combination with Hycamtin may reduce chemotherapy-induced myelosuppression in small cell lung cancer, according to one expert.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other